ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
Delayed Nasdaq  -  04:00 2022-08-18 pm EDT
17.34 USD   -1.70%
08/09ROCKET PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/09Raymond James Adjusts Rocket Pharmaceuticals' Price Target to $24 From $22, Maintains Outperform Rating
MT
08/08ROCKET PHARMACEUTICALS : Reports Second Quarter 2022 Financial Results and Highlights Recent Progress - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ROCKET PHARMACEUTICALS, INC.
Upcoming events on ROCKET PHARMACEUTICALS, INC.
09/07/22 Citi BioPharma Conference
09/12/22 Morgan Stanley Global Healthcare Conference
11/09/22 Q3 2022 Earnings Release (Projected)
03/09/23 FY 2022 Earnings Release (Projected)
05/10/23 Q1 2023 Earnings Release (Projected)
Past events on ROCKET PHARMACEUTICALS, INC.
08/10/22 Interim 2022 Earnings Release (Projected)
07/11/22 | 09:00am William Blair Biotech Focus Conference
06/13/22 | 09:00am Annual General Meeting
05/24/22 | 07:45am UBS Global Healthcare Conference
05/19/22 | 08:00am American society of gene and cell therapy conference - abstract number: 1188
05/16/22 | 05:30pm American society of gene and cell therapy conference - abstract number: 357
05/16/22 | 04:15pm American society of gene and cell therapy conference - abstract number: 108
05/16/22 | 10:45am American society of gene and cell therapy conference - abstract number: 24
05/11/22 | 02:20pm Bank of America Healthcare Conference
05/05/22 | 04:01pm Q1 2022 Earnings Release
Past dividends on ROCKET PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread


 


 


 


 


 
 
0,13
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-70,8
-63,0
-12%
-76,1
-91,0
16%
-133
-102
-31%
-164
-153
-7,3%
 
-189
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-26,7
-31,0
14%
-71,2
-62,1
-15%
-76,2
-82,7
7,9%
-134
-104
-29%
-167
-170
1,6%
 
-206
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-74,5
-65,2
-14%
-77,3
-84,7
8,8%
-140
-110
-28%
-169
-172
1,5%
 
-209
 
Net income
M $
Released
Forecast
Spread


 
-74,5
-65,2
-14%
-77,3
-84,1
8,1%
-140
-109
-28%
-169
-172
1,5%
 
-203
 
EPS
$
Released
Forecast
Spread


 
-1,89
-1,66
-14%
-1,58
-1,68
5,7%
-2,52
-1,93
-30%
-2,67
-2,64
-1,2%
 
-3,06
 
Announcement Date03/07/201803/07/201903/05/202002/25/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread


 


 


 


 


 
 

 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-33,3
-36,5
8,6%
-48,8
-40,8
-20%
-43,3
-44,5
2,6%


 

-43,6
 
 
-41,7
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-34,0
-40,3
15%

-37,3
 
-44,3
-46,2
4,0%
-42,6
-48,0
11%
-54,2
-44,4
-22%
 
-53,3
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-34,5
-42,8
19%

-35,3
 
-44,2
-45,3
2,2%
-43,0
-47,0
8,5%
-54,4
-44,6
-22%
 
-54,6
 
Net income
M $
Released
Forecast
Spread
-34,5
-41,5
17%

-36,7
 
-44,2
-46,0
3,8%
-43,0
-46,7
8,0%
-54,4
-44,5
-22%
 
-52,1
 
EPS
$
Released
Forecast
Spread
-0,55
-0,66
16%

-0,62
 
-0,69
-0,73
5,4%
-0,67
-0,70
4,7%
-0,83
-0,68
-22%
 
-0,79
 
Announcement Date08/09/202111/03/202102/24/202205/05/202208/08/2022-
Previous year Next Year
Upcoming sector events for ROCKET PHARMACEUTICALS, INC.
More events
Past sector events for ROCKET PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise